(Circulation. 1999;100:2319.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Estrogen and Progesterone Reduce Lipid Accumulation in Human Monocyte-Derived Macrophages
A Sex-Specific Effect
From the Heart Research Institute (J.A.M., S.N., W.J., K.K.S., D.S.C.) and Department of Cardiology (J.A.M., D.S.C.), Royal Prince Alfred Hospital, Camperdown, Sydney, Australia, and Department of Medicine (D.S.C.), University of Sydney, Camperdown, Sydney, Australia. Dr Stanley is currently at The Centre for Immunology, University of NSW and St Vincent’s Hospital, Darlinghurst, Sydney, Australia.
Correspondence to David S. Celermajer, Department of Cardiology, Royal Prince Alfred Hospital, Missenden Rd, Camperdown 2050, Sydney, Australia. E-mail davidc{at}card.rpa.cs.nsw.gov.au
Background—Males have an earlier onset and greater prevalence of clinical atherosclerosis than age-matched females, which is consistent with an atheroprotective effect of the female sex steroids, estrogen and progesterone. We therefore examined the effects of estrogen and progesterone on human foam cell formation, a key early event in atherogenesis.
Methods and Results—Monocytes from healthy female and male donors were obtained from white cell concentrates and allowed to differentiate into macrophages over 10 days. These human monocyte-derived macrophages (MDMs) were exposed to either control (0.1% vol/vol ethanol) or estrogen or progesterone treatment on days 3 through 10. Lipid loading was achieved on days 8 through 10 by incubation with acetylated LDL. Lipid from the MDMs was then extracted for analysis of cholesteryl ester (CE) content. 17ß-Estradiol at both physiological (2 nmol/L) and supraphysiological (20 and 200 nmol/L) concentrations produced a significant reduction in macrophage CE content (88±3%, 88±2%, and 85±4%, respectively; P<0.02 compared with control). Physiological and supraphysiological levels of progesterone (2, 10, and 200 nmol/L) produced an even more dramatic reduction in CE content (74±9%, 56±10%, and 65±8%, respectively; P<0.002 compared with control). This effect could be abrogated by coincubation with the progesterone receptor antagonist RU486. Neither estrogen nor progesterone produced a reduction in lipid loading in male-donor–derived MDMs. Detailed lipid trafficking studies demonstrated that both estrogen and progesterone altered macrophage uptake and/or processing of modified LDL.
Conclusions—Physiological levels of estrogen and progesterone are associated with a female-sex–specific reduction in human macrophage lipid loading, which is consistent with an atheroprotective effect.
Key Words: cells • atherosclerosis • lipoproteins • lipids
This article has been cited by other articles:
 |
|
 |
|
  M. Subramanian and C. Shaha Up-Regulation of Bcl-2 through ERK Phosphorylation Is Associated with Human Macrophage Survival in an Estrogen Microenvironment J. Immunol., August 15, 2007; 179(4): 2330 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stygar, B. Masironi, H. Eriksson, and L. Sahlin Studies on estrogen receptor (ER) {alpha} and {beta} responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists J. Endocrinol., July 1, 2007; 194(1): 101 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zitzmann, M. Erren, A. Kamischke, M. Simoni, and E. Nieschlag Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6603 - 6608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Y. Liu, R. C. Christian, M. Ruan, V. M. Miller, and L. A. Fitzpatrick Correlating Androgen and Estrogen Steroid Receptor Expression with Coronary Calcification and Atherosclerosis in Men without Known Coronary Artery Disease J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1041 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. C. Ng, S. Nakhla, A. Baoutina, W. Jessup, D. J. Handelsman, and D. S. Celermajer Dehydroepiandrosterone, an adrenalandrogen, increases human foam cell formation: a potentially pro-atherogenic effect J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1967 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. C. Ng, C. M. Quinn, J. A. McCrohon, S. Nakhla, W. Jessup, D. J. Handelsman, D. S. Celermajer, and A. K. Death Androgens Up-Regulate Atherosclerosis-Related Genes in Macrophages From Males But Not Females: Molecular Insights Into Gender Differences in Atherosclerosis J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1306 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Sullivan, J. E. Evans, J. M. Cermak, K. L. Krenzer, M. R. Dana, and D. A. Sullivan Complete Androgen Insensitivity Syndrome: Effect on Human Meibomian Gland Secretions Arch Ophthalmol, December 1, 2002; 120(12): 1689 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K.C. Ng, P. Y. Liu, A. J. Williams, S. Nakhla, L. P. Ly, D. J. Handelsman, and D. S. Celermajer Prospective Study of Effect of Androgens on Serum Inflammatory Markers in Men Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1136 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Christian, S. Harrington, W. D. Edwards, A. L. Oberg, and L. A. Fitzpatrick Estrogen Status Correlates with the Calcium Content of Coronary Atherosclerotic Plaques in Women J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1062 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Rossouw Hormones, genetic factors, and gender differences in cardiovascular disease Cardiovasc Res, February 15, 2002; 53(3): 550 - 557. [Full Text] [PDF]
|
|
|
|
|
|
P. S. Jhund, N. Dawson, A. P. Davie, N. Sattar, J. Norrie, K. P. J. O'Kane, and J. J. V. McMurray Attenuation of endothelin-1 induced vasoconstriction by 17{beta} estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1367 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Do Female Hormones Affect Atherosclerosis Development? Journal Watch Women's Health, February 1, 2000; 2000(201): 19 - 19. [Full Text]
|
|
|
|
 |
|
 J. A. McCrohon, A. K. Death, S. Nakhla, W. Jessup, D. J. Handelsman, K. K. Stanley, and D. S. Celermajer Androgen Receptor Expression Is Greater in Macrophages From Male Than From Female Donors : A Sex Difference With Implications for Atherogenesis Circulation, January 25, 2000; 101(3): 224 - 226. [Abstract] [Full Text] [PDF]
|
|